Pyrexia, commonly known as fever, is a frequent clinical symptom encountered in practice, often indicative of underlying pathologies. Despite its ubiquity, its management can often be complex and multifaceted, necessitating a comprehensive understanding of its etiology, pathophysiology, and the latest treatment approaches.
Pyrexia results from an elevation in the body's set-point temperature, often triggered by pyrogens, substances typically produced in response to infection or inflammation. These pyrogens stimulate the hypothalamus, leading to the production of prostaglandins, which ultimately raise the body's temperature set-point.
A thorough clinical assessment is vital in managing pyrexia. It should include a detailed history, physical examination, and relevant investigations. The primary aim is to identify the source of infection or inflammation causing the fever. In some cases, pyrexia may be a symptom of non-infectious diseases such as malignancies or autoimmune disorders.
Treatment of pyrexia primarily involves addressing the underlying cause. Antipyretics can be used to provide symptomatic relief, but they do not treat the root cause. In cases of bacterial infection, antibiotics are the mainstay of treatment, while antivirals or antifungals may be required for viral or fungal infections, respectively. Non-pharmacological interventions, such as maintaining hydration and cooling measures, also play a key role.
In pediatric and geriatric populations, fever management requires particular attention due to differences in physiological responses and potential complications. Similarly, immunocompromised patients may present with atypical symptoms and have a higher risk of severe infections, necessitating a more cautious approach.
Managing pyrexia in clinical practice is a common but challenging task, requiring a thorough understanding of its causes, clinical assessment, and treatment strategies. By staying up-to-date with the latest research and guidelines, healthcare professionals can ensure effective management of pyrexia, ultimately improving patient outcomes.
1.
Chiauranib Slows Platinum-Resistant Ovarian Cancer
2.
Radioiodine therapy found to improve relative survival rates of differentiated thyroid cancer patients
3.
Le cancer et le COVID ont conduit le patient à une double transplantation de poumon.
4.
Remote monitoring can improve recovery from cancer surgery
5.
Whole Foods Recall; RFK Jr.'s Voting Problem; Glass Particles in Biosimilar
1.
Innovative Methods in Oncology in the Digital Era
2.
Uncovering Breast Cancer: The Power of Early Stage Ultrasound
3.
Exploring the Potential of Xospata: A New Frontier in Cancer Treatment
4.
The Future is Now: Navigating the Precision Revolution in Oncology Treatment
5.
Immune Landscape Evolution in the Tumor Stromal Ecosystem
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
2.
Exploring Potentials of Lorlatinib: The Third Generation ALK-TKI Through CROWN Trial
3.
The Role of Emotional Support During Cancer Recovery
4.
Best Practices in Hematology
5.
Navigating the Complexities of Ph Negative ALL - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation